Search Results - "Bhawsar, Satish"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Synthesis and evaluation of novel biaryl oxazolidinones effective against gram-positive bacterial infections by Bhawsar, Satish, Shaikh, Mohammad, Joshi, Sanjeev, Mishra, Amit, Pavase, Laxmikant, Chavan, Vijay, Kale, Amol, Kayastha, Abhijeet K., Yeole, Ravindra, Bhagwat, Sachin, Patel, Mahesh

    Published in Medicinal chemistry research (01-10-2024)
    “…Oxazolidinones are synthetic antibiotic class of compounds characterized by chemical structure, cyclic carbamate with ‘ S’ configuration of substituent at C -5…”
    Get full text
    Journal Article
  2. 2

    Nafithromycin (MIQNAF®): ultramodern lactone ketolide designed to treat community acquired bacterial pneumonia (CABP) by Bhawsar, Satish, Tadiparthi, Ravikumar, Kayastha, Abhijeet K., Dixit, Prasad, Pavase, Laxmikant, Mishra, Amit, Chavan, Vijay, Birajdar, Satish, Shaikh, Mohammad, Yeole, Ravindra, Bhagwat, Sachin, Patel, Mahesh

    Published in Medicinal chemistry research (01-10-2024)
    “…Community acquired bacterial pneumoniae (CABP) infections is the major cause of mortality and morbidity, especially in elderly patients. India accounts for 23%…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection by Bhawsar, Satish, Kale, Rajesh, Deshpande, Prasad, Yeole, Ravindra, Bhagwat, Sachin, Patel, Mahesh

    Published in Bioorganic & medicinal chemistry letters (15-12-2021)
    “…Injectable and oral prodrug of levonadifloxacin with widely differing solubility and oral bioavailability. [Display omitted] Levonadifloxacin is a parenteral…”
    Get full text
    Journal Article
  5. 5

    WCK 4034: A promising oxazolidinone for treating gram positive infections by Bhawsar, Satish, Pawar, Shivaji, Deshpande, Prasad, Yeole, Ravindra, Chavan, Rajesh, Nandanwar, Manohar, Bhagwat, Sachin, Patel, Mahesh

    Published in Bioorganic & medicinal chemistry letters (01-09-2022)
    “…[Display omitted] Increased resistance to gram positive infections have highlighted the limitations of currently available drug treatments including…”
    Get full text
    Journal Article
  6. 6

    WCK 1152, WCK 1153: Discovery and structure activity relationship for the treatment of resistant pneumococcal and staphylococcal respiratory infections by Bhawsar, Satish, Joshi, Sanjeev, Deshpande, Prasad, Yeole, Ravindra, Bhagwat, Sachin, Patel, Mahesh

    Published in Bioorganic & medicinal chemistry letters (01-05-2022)
    “…[Display omitted] Novel antibacterial agents needed constantly to counter the ever emergent resistance development to commercially available drugs; one of the…”
    Get full text
    Journal Article
  7. 7